THE ENCEPHALOMYOCARDITIS VIRUS (EMCV) AND ITS ZOONOTIC POTENTIAL (A LITERATURE REVIEW). PART II. PATHOGENESIS. THE CIRCLE OF SUSCEPTIBLE ORGANISMS
https://doi.org/10.25207/1608-6228-2019-26-3-117-128
Abstract
According to literature data, both the direct action of (B2 *, L, 2A) viral proteins and the inflammatory response of the body are distinguished among the Encephalomyocarditis virus (EMCV) virulence factors. Depending on the EMCV strain and the type of the infected animal, the severity and nature of the disease is shown to be characterized by specific clinical manifestations. Differences in the pathogenetic mechanisms of tissue lesions depending on the magnitude of the virus infectious dose are established, e.g., in the development of EMCV-induced diabetes. The EMCV action was studied in vivo on such experimental animals as pigs, rodents and monkeys. The range of affected animals is extremely wide, with the infection being common almost everywhere. Thus, numerous works describe a fairly high immunological stratum among people, as well as disease outbreaks among the population. It is concluded that EMCV is dangerous not only for zoos and primatological centres, but also has a clear zoonotic potential.
About the Authors
Akop A. Kalajdzhjan
Scientifc Research Institute of Medical Primatology
Russian Federation
Russian Federation
PhD Researcher, Laboratory of Molecular Biology,
Mira str., 177, Sochi, 354376
Azamat Kh. Kade
Kuban State Medical University, Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
Dr. Sci. (Med.), Prof., Head of Department, Department of General and Clinical Pathological Physiology,
Mitrofanа Sedinа str., 4, Krasnodar, 350063
Pavel P. Polyakov
Kuban State Medical University, Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
Research Assistant, Department of General and Clinical Pathological Physiology,
Mitrofanа Sedinа str., 4, Krasnodar, 350063;
tel.:+7 (861) 262-40-31
Alla I. Gudmanova
Krasnodar City Clinical Hospital No. 3, Ministry of Healthcare of Krasnodar Krai
Russian Federation
Russian Federation
Physician,
Aivazovskogo str., 97, Krasnodar, 350040
References
1. Carocci M., Bakkali-Kassimi L. The encephalomyocarditis virus. Virulence. 2012; 3 (4): 351–367. DOI: 10.4161/viru.20573
2. Loughran G., Firth A.E., Atkins J.F. Ribosomal frameshifting into an overlapping gene in the 2B-encoding region of the cardiovirus genome. Proc. Natl. Acad. Sci. USA. 2011; 108(46): E1111–E1119. DOI: 10.1073/pnas.1102932108
3. Balvay L., Soto Rifo R., Ricci E.P., Decimo D., Ohlmann T. Structural and functional diversity of viral IRESes. Biochim. Biophys. Acta. 2009; 1789(9-10): 542–557. DOI: 10.1016/j.bbagrm.2009.07.005
4. Papon L., Oteiza A., Imaizumi T., Kato H., Brocchi E., Lawson T.G., Akira S., Mechti N. The viral RNA recognition sensor RIG-I is degraded during encephalomyocarditis virus (EMCV) infection. Virology. 2009; 393(2): 311–318. DOI: 10.1016/j.virol.2009.08.009
5. de Jong A.S., de Mattia F., Van Dommelen M.M., Lanke K., Melchers W.J., Willems P.H., van Kuppeveld F.J. Functional analysis of picornavirus 2B proteins: effects on calcium homeostasis and intracellular protein traffcking. J. Virol. 2008; 82(7): 3782–3790. DOI: 10.1128/JVI.02076-07
6. Choe S.S., Dodd D.A., Kirkegaard K. Inhibition of cellular protein secretion by picornaviral 3A proteins. Virology. 2005; 337(1): 18–29. DOI: 10.1016/j.virol.2005.03.036
7. Moffat K., Knox C., Howell G., Clark S.J., Yang H., Belsham G.J., Ryan М., Wileman Т. Inhibition of the secretory pathway by foot-and-mouth disease virus 2BC protein is reproduced by coexpression of 2B with 2C, and the site of inhibition is determined by the subcellular location of 2C. J. Virol. 2007; 81(3): 1129–1139. DOI: 10.1128/JVI.00393-06
8. Canelli E., Luppi A., Lavazza A., Lelli D., Sozzi E., Martin A.M., Gelmetti D., Pascotto E., Sandri C., Magnone W., Cordioli P. Encephalomyocarditis virus infection in an Italian zoo. Virol. J. 2010; 7: 64. DOI: 10.1186/1743-422X-7-64
9. Czechowicz J., Huaman J.L., Forshey B.M., Morrison A.C., Castillo R., Huaman A., Caceda R., Eza D., Rocha C., Blair P.J., Olson J.G., Kochel T.J. Prevalence and risk factors for encephalomyocarditis virus infection in Peru. Vector. Borne. Zoonotic. Dis. 2011; 11(4): 367–374. DOI: 10.1089/vbz.2010.0029
10. Oberste M.S., Gotuzzo E., Blair P., Nix W.A., Ksiazek T.G., Comer J.A., Rollin Р., Goldsmith С.S., Olson J., Koche T.J. Human febrile illness caused by encephalomyocarditis virus infection, Peru. Emerg. Infect. Dis. 2009; 15(4): 640–646. DOI: 10.3201/eid1504.081428
11. An D.-J., Jeong W., Jeoung H.-Y., Yoon S.H., Kim H.J., Choi C.U., Park B.K. Encephalomyocarditis in Korea: serological survey in pigs and phylogenetic analysis of two historical isolates. Vet. Microbiol. 2009; 137(1–2): 37–44. DOI: 10.1016/j.vetmic.2009.01.005
12. Ge X., Zhao D., Liu C., Wang F., Guo X, Yang H. Seroprevalence of encephalomyocarditis virus in intensive pig farms in China. Vet. Rec. 2010; 166(5): 145–146. DOI: 10.1136/vr.b4766
13. Billinis C. Encephalomyocarditis virus infection in wildlife species in Greece. J. Wildl. Dis. 2009; 45(2): 522–526.
14. Psalla D., Psychas V., Spyrou V., Billinis C., Papaioannou N., Vlemmas I. Pathogenesis of experimental encephalomyocarditis: a histopathological, immunohistochemical and virological study in rats. J. Comp. Pathol. 2006; 134(1): 30–39. DOI: 10.1016/j.jcpa.2005.06.008
15. Spyrou V., Maurice H., Billinis C., Papanastassopoulou M., Psalla D., Nielen M. Transmission and pathogenicity of encephalomyocarditis virus (EMCV) among rats. Vet. Res. 2004; 35(1): 113–122. DOI: 10.1051/vetres:2003044
16. Kluivers M., Maurice H., Vyt P., Koenen F., Nielen M. Transmission of encephalomyocarditis virus in pigs estimated from feld data in Belgium by means of R0. Vet Res. 2006; 37(6): 757–766. DOI: 10.1051/vetres:2006035
17. Koenen F. Chapter 17: Encephalomyocarditis Virus. In: Straw B.E., D’Allaire S., Zimmerman J.J., Taylor D.J, editors. Disease of the Swine. 9th ed. Boston: Blackwell Science; 2006.
18. Juncker-Voss M., Prosl H., Lussy H., Enzenberg U., Auer H., Lassnig H., Müller M., Nowotny N. Screening for antibodies against zoonotic agents among employees of the Zoological Garden of Vienna, Schönbrunn, Austria. Berl. Munch. Tierarztl. Wochenschr. 2004; 117(9–10): 404–409.
19. Masek-Hammerman K., Miller A.D., Lin K.C., MacKey J., Weissenböck H., Gierbolini L., Burgos A., Perez H., Mansfeld K.G. Epizootic myocarditis associated with encephalomyocarditis virus in a group of rhesus macaques (Macaca mulatta). Vet. Pathol. 2012; 49(2): 386–392. DOI: 10.1177/0300985811409254
20. Gelmetti D., Meroni A., Brocchi E., Koenen F., Cammarata G. Pathogenesis of encephalomyocarditis experimental infection in young piglets: a potential animal model to study viral myocarditis. Vet Res. 2006; 37(1): 15–23. DOI: 10.1051/vetres:2005041
21. Psalla D., Psychas V., Spyrou V., Billinis C., Papaioannou N., Vlemmas I. Pathogenesis of experimental encephalomyocarditis: a histopathological, immunohistochemical and virological study in mice. J. Comp. Pathol. 2006; 135(2–3): 142–145. DOI: 10.1016/j.jcpa.2006.04.003
22. Yoon J.-W., Jun H.-S. Viruses cause type 1 diabetes in animals. Ann. NY Acad. Sci. 2006; 1079(1): 138–146. DOI: 10.1196/annals.1375.021
23. Nakayama Y., Su W., Ohguchi A., Nakayama H., Doi K. Experimental encephalomyocarditis virus infection in pregnant mice. Exp. Mol. Pathol. 2004; 77(2): 133–137. DOI: 10.1016/j.yexmp.2004.02.003
24. Yamanouchi-Ueno A., Nakayama Y., Doi K. Characteristics of testicular lesions in mice infected with a low dose of encephalomyocarditis (EMC) virus. Exp. Mol. Pathol. 2004; 77(2): 72–76. DOi: 10.1016/j.yexmp.2003.12.008
25. Doi K. Experimental encephalomyocarditis virus infection in small laboratory rodents. J. Comp. Pathol. 2011; 144(1): 25–40. DOI: 10.1016/j.jcpa.2010.05.001
26. Matsumori A., Yamamoto K., Shimada M. Cetirizine a histamine H1 receptor antagonist improves viral myocarditis. J. Inflamm. (Lond). 2010; 7: 39. DOI: 10.1186/1476-9255-7-39
27. Wang J.-F., Meissner A., Malek S., Chen Y., Ke Q., Zhang J., Chu V., Hampton T.G., Crumpacker C.S., Abelmann W.H., Amende I., Morgan J.P. Propranolol ameliorates and epinephrine exacerbates progression of acute and chronic viral myocarditis. Am. J. Physiol. Heart Circ. Physiol. 2005; 289(4): H1577–1583. DOI: 10.1152/ajpheart.00258.2005
28. Matsumori A., Nunokawa Y., Yamaki A., Yamamoto K., Hwang M.W., Miyamoto T., Hara M., Nishio R., Kitaura-Inenaga K., Ono K. Suppression of cytokines and nitric oxide production, and protection against lethal endotoxemia and viral myocarditis by a new NF-kappaB inhibitor. Eur. J. Heart. Fail. 2004; 6(2): 137–144. DOI: 10.1016/j.ejheart.2003.10.007
29. Nasu-Nishimura Y., Taniuchi Y., Nishimura T., Sakudo A., Nakajima K., Ano Y., Sugiura K., Sakaguchi S., Itohara S., Onodera T. Cellular prion protein prevents brain damage after encephalomyocarditis virus infection in mice. Arch. Virol. 2008; 153(6): 1007–1012. DOI: 10.1007/s00705-008-0086-x
30. Takeda M., Ohtsuka R., Nakayama Y., Doi K. The role of CD4(+) T cells in biphasic hind limb paralysis induced by the D variant of encephalomyocarditis virus (EMC-D) in DBA/2 mice. Exp. Anim. 2004; 53(1): 31–35.
31. Ano Y., Sakudo A., Kimata T., Uraki R., Sugiura K., Onodera T. Oxidative damage to neurons caused by the induction of microglial NADPH oxidase in encephalomyocarditis virus infection. Neurosci. Lett. 2010; 469(1): 39–43. DOI: 10.1016/j.neulet.2009.11.040
32. Bardina M.V., Lidsky P.V., Sheval E.V., Fominykh K.V., van Kuppeveld F.J., Polyakov V.Y., Agol V.I. Mengovirus-induced rearrangement of the nuclear pore complex: hijacking cellular phosphorylation machinery. J. Virol. 2009; 83(7): 3150–3161. DOI: 10.1128/JVI.01456-08
33. Porter F.W., Brown B., Palmenberg A.C. Nucleoporin phosphorylation triggered by the encephalomyocarditis virus leader protein is mediated by mitogen-activated protein kinases. J. Virol. 2010; 84(24): 12538–12548. DOI: 10.1128/JVI.01484-09
34. Porter F.W., Palmenberg A.C. Leader-induced phosphorylation of nucleoporins correlates with nuclear traffcking inhibition by cardioviruses. J. Virol. 2009; 83(4): 1941–1951. DOI: 10.1128/JVI.01752-08
35. Porter F.W., Bochkov Y.A., Albee A.J., Wiese C., Palmenberg A.C. A picornavirus protein interacts with Ran-GTPase and disrupts nucleocytoplasmic transport. Proc. Natl. Acad. Sci. USA. 2006; 103(33): 12417–12422. DOI: 10.1073/pnas.0605375103
36. Borghese F., Michiels T. The leader protein of cardioviruses inhibits stress granule assembly. J. Virol. 2011; 85(18): 9614–9622. DOI: 10.1128/JVI.00480-11
37. Okuwa T., Taniura N., Saito M., Himeda T., Ohara Y. Opposite effects of two nonstructural proteins of Theiler’s murine encephalomyelitis virus regulates apoptotic cell death in BHK-21 cells. Microbiol. Immunol. 2010; 54(10): 639–643. DOI: 10.1111/j.1348-0421.2010.00260.x
38. Groppo R., Palmenberg A.C. Cardiovirus 2A protein associates with 40S but not 80S ribosome subunits during infection. J. Virol. 2007; 81(23): 13067–13074. DOI: 10.1128/JVI.00185-07
39. Groppo R., Brown B.A, Palmenberg A.C. Mutational analysis of the EMCV 2A protein identifes a nuclear localization signal and an eIF4E binding site. Virology. 2011; 410(1): 257–267. DOI: 10.1016/j.virol.2010.11.002
40. Ohguchi A., Nakayama Y., Yasoshima A., Doi C., Mikami T., Uetsuka K., Doi K. Encepalomyocarditis virus-induced apoptosis and ultrastructural changes in the lacrimal and parotid glands of mice. Exp. Mol. Pathol. 2006; 80(2): 201–207. DOI: 10.1016/j.yexmp.2005.06.003
41. Buenz E.J., Sauer B.M., Lafrance-Corey R.G., Deb C., Denic A., German C.L., Howe C.L. Apoptosis of hippocampal pyramidal neurons is virus independent in a mouse model of acute neurovirulent picornavirus infection. Am. J. Pathol. 2009; 175(2): 668–684. DOI: 10.2353/ajpath.2009.081126
42. Roos F.C., Roberts A.M, Hwang I.I.L, Moriyama E.H, Evans A.J., Sybingco S., Watson I.R., Carneiro L.A., Gedye C., Girardin S.E., Ailles L.E., Jewett M.A., Milosevic M., Wilson B.C., Bell J.C., Der S.D., Ohh M. Oncolytic targeting of renal cell carcinoma via encephalomyocarditis virus. EMBO Mol. Med. 2010; 2(7): 275–288. DOI: 10.1002/emmm.201000081
43. Christmann B.S., Moran J.M., McGraw J.A., Buller R.M.L., Corbett J.A. Ccr5 Regulates Inflammatory Gene Expression in Response to Encephalomyocarditis Virus Infection. Am. J. Pathol. 2011; 179(6): 2941–2951. DOI: 10.1016/j.ajpath.2011.08.012
44. Luo Y.K., Liang L., Tang Q.H., Zhou L., Shi L.J., Cong Y.Y., Lin W.C., Cui S.J. Isolation and characterization of encephalomyocarditis virus from dogs in China Sci. Rep. 2017; 7(1): 438. DOI: 10.1038/s41598-017-00435-x
45. Maurice H., Nielen M., Brocchi E., Nowotny N., Kassimi L.B., Billinis C. The occurrence of encephalomyocarditis virus (EMCV) in European pigs from 1990 to 2001. Epidemiol. Infect. 2005; 133(3): 547–557. DOI: 10.1017/S0950268804003668
46. Higuchi H., Hara M., Yamamoto K., Miyamoto T., Kinoshita M., Yamada T., Uchiyama K., Matsumori A. Mast cells play a critical role in the pathogenesis of viral myocarditis. Circulation. 2008; 118(4): 363–372. DOI: 10.1161/CIRCULATIONAHA.107.741595
47. Onodera T., Yoon J.W., Brown K.S., Notkina A.L. Evidence for a single locus controlling susceptibility to virus-induced diabetes mellitus. Nature. 1978; 274: 693–696. DOI: 10.1038/274693a0
48. Aminev A.G., Amineva S.P., Palmenberg A.C. Encephalomyocarditis viral protein 2A localizes to nucleoli and inhibits cap-dependent mRNA translation. Virus. Res. 2003; 95(1–2): 45–57. DOI: 10.1016/S0168-1702(03)00162-X
49. Martin L.R., Neal Z.C., McBride M.S., Palmenberg A.C. Mengovirus and encephalomyocarditis virus poly(C) tract lengths can affect virus growth in murine cell culture. J. Virol. 2000; 74(7): 3074–3081. DOI: 10.1128/JVI.74.7.3074-3081.2000
50. Banerjee R., Tsai W., Kim W., Dasgupta A. Interaction
51. of poliovirus-encoded 2C/2BC polypeptides with the
52. ′ terminus negative-strand cloverleaf requires an
53. intact stem-loop b. Virology. 2001; 280 (1):41–51.
54. DOI: 10.1006/viro.2000.0770
55. Helwig F.C., Schmidt C.H. A flter-passing agent
56. producing interstitial myocarditis in anthropoid apes
57. and small animals. Science. 1945; 102(2637): 31–33.
58. DOI: 10.1126/science.102.2637.31
59. Dea S., Bilodeau R., Sauvageau R., Martineau G.P.
60. Outbreaks in Quebec pig farms of respiratory and
61. reproductive problems associated with encephalomyocarditis virus. J. Vet. Diagn. Invest. 1991; 3(4):
62. –282. DOI: 10.1177/104063879100300401
Review
For citations:
Kalajdzhjan A.A., Kade A.Kh., Polyakov P.P., Gudmanova A.I. THE ENCEPHALOMYOCARDITIS VIRUS (EMCV) AND ITS ZOONOTIC POTENTIAL (A LITERATURE REVIEW). PART II. PATHOGENESIS. THE CIRCLE OF SUSCEPTIBLE ORGANISMS. Kuban Scientific Medical Bulletin. 2019;26(3):117-128. (In Russ.) https://doi.org/10.25207/1608-6228-2019-26-3-117-128
Views:
939
Email this article 